Quality monitoring of acute stroke care in rhineland-palatinate, Germany, 2001-2006

Stroke

Volumn 41, Issue 7, 2010, Pages 1495-1500

  Grau, Armin J ^a   Eicke, Martin ^b   Biegler, Marcel K ^c   Faldum, Andreas ^d   Bamberg, Christian ^e   Haass, Anton ^f   Hardt, Roland ^g   Hufschmidt, Andreas ^h   Lowitzsch, Klaus ^a   Marx, Jürgen ⁱ   Schmitt, Eberhard ^j   Schoenemann, Hartmut ^e   Von Arnim, Wolf ^b   Weiss, Hagen ^k   Dienlin, Sieghard ^c  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b Klinikum Idar Oberstein GmbH   (Germany)

^c SQMed GmbH   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e Rhein Mosel Fachklinik Andernach ^*  (Germany)

^f SAARLAND UNIVERSITY   (Germany)

^g St Hildegardis Krankenhaus   (Germany)

^h Department of Neurology   (Germany)

ⁱ JOHANNES GUTENBERG UNIVERSITY   (Germany)

^j Katholisches Klinikum Koblenz   (Germany)

^k Department of Internal Medicine   (Germany)

more..

Author keywords

quality monitoring; secondary prevention; stroke units; thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; EMERGENCY HEALTH SERVICE; FEMALE; FIBRINOLYTIC THERAPY; GERMANY; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HOSPITAL CARE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SECONDARY PREVENTION; STROKE; TREND STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; HOSPITAL SUBDIVISIONS AND COMPONENTS; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; REGISTER; RISK FACTOR; STANDARD; TIME;

AGED; AGED, 80 AND OVER; FEMALE; GERMANY; HOSPITAL UNITS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; REGISTRIES; RISK FACTORS; STROKE; TIME FACTORS;

EID: 77954174184     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.582239     Document Type: Article

References (16)

1. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457-507.
2. Asplund K, Hulter-Åsberg K, Norrving B, Stegmayr B, Terént A, Wester PO. Riks-Stroke: a Swedish national quality register for stroke care. Cerebrovasc Dis. 2003;15(suppl 1):5-7.
3. Kapral MK, Laupacis A, Phillips SJ, Silver FL, Hill MD, Fang J, Richards J, Tu JV. Investigators of the Registry of the Canadian Stroke Network. Stroke care delivery in institutions participating in the Registry of the Canadian Stroke Network. Stroke. 2004;35:1756-1762.
4. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, Hermanek P, Leffmann C, Janzen RWC, Röther J, Buecker-Nott HJ, Berger K, for the German Stroke Registers Study Group. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke. Arch Intern Med. 2004;164:1761-1768
5. The Paul Coverdell Prototype Registries Writing Group. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke registry. Stroke. 2005;36:1232-1240.
6. Sposato LA, Esnaola MM, Zamora R, Zurrú MC, Fustinoni O, Saposnik G, on behalf of ReNACer Investigators and the Argentinian Neurological Society. Quality of ischemic stroke care in emerging countries: the Argentinian National Stroke Registry (ReNACer). Stroke. 2008;39: 3036-3041.
7. Heuschmann PU, Biegler MK, Busse O, Elsner S, Grau A, Hasenbein U, Hermanek P, Janzen RWC, Kolominsky-Rabas PL, Kraywinkel K, Low-itzsch K, Misselwitz B, Nabavi DG, Otten K, Pientka L, von Reutern GM, Ringelstein GB, Sander D, Wagner M, Berger K. Development and implementation of evidence-based indicators for measuring quality of acute stroke care. The quality indicator board of the German Stroke Registers Study Group (ADSR). Stroke. 2006;37:2573-2578.
8. Busse O. Stroke units and stroke services in Germany. Cerebrovasc Dis. 2003;15(suppl 1):8-10.
9. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
10. Feigin VL, Lawes CMM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2:43-53.
11. Deng YZ, Reeves MJ, Jacobs BS, Birbeck GL, Kothari RU, Hicken-bottom SL, Mullard AJ, Wehner S, Maddox K, Majid A, for the Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry. Neurology. 2006;66:306-312.
12. Birbeck GL, Cui X, Zingmond DS, Vickrey BG. IV-tPA use in California: resources and recipients. Cerebrovasc Dis. 2004;17:341-343.
13. Nadeau JO, Shi S, Fang J, Kapral MK, Richards JA, Silver FL, Hill MD, on behalf of the investigators for the Registry of the Canadian Stroke Network. tPA use for stroke in the Registry of the Canadian Stroke Network. Can J Neurol Sci. 2005;32:433-439.
14. Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C, Cheung AM; for the Investigators of the Registry of the Canadian Stroke Network. Sex differences in stroke care and outcomes: results from the registry of the Canadian Stroke Network. Stroke. 2005;36:809-814.
15. Glader EL, Stegmayr B, Norrving B, Terént A, Hulter-Asberg K, Wester PO, Asplund K. Riks-Stroke Collaboration: large variations in the use of oral anticoagulants in ischemic stroke patients with atrial fibrillation: a Swedish national perspective. J Intern Med. 2004:255:22-32.
16. Diener HC, Allenberg JR, Bode C, Busse O, Forsting M, Grau AJ, Haberl RL, Hacke W, Hamann GF, Hennerici M, Grond M, Ringelstein EB, Ringleb PA. Leitlinie Primär-und Sekundärprävention der zerebralen Ischämie. III ed. Stuttgart/New York; Thieme: 2005.